Chronic Rhinosinusitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CNTB | C | Connect Biopharma Holdings Limited | -1.49 | |
LYRA | D | Lyra Therapeutics, Inc. | 0.00 | |
OPTN | F | OptiNose, Inc. | -2.91 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DWAS | C | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.34 | |
IWC | C | iShares Microcap ETF | 0.05 | |
IWO | C | iShares Russell 2000 Growth ETF | 0.01 | |
AVSC | C | Avantis U.S. Small Cap Equity ETF | 0.01 | |
DFAS | C | Dimensional U.S. Small Cap ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is a long-term inflammation of the nasal passages and sinuses. It is a common condition that affects millions of people worldwide. Symptoms of CRS include nasal congestion, facial pain, postnasal drip, and a decreased sense of smell. Treatment options include medications, nasal irrigation, and surgery.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles